Considering its unique distribution in the brain and its involvement in neuronal differentiation [1], [9], [11], further studies accounting for the genetic backgrounds should address potential compensatory effects and the further potential of GPR12 as a drug target for psychopathology and metabolic disorders. Here, GPR12 is linked to Other metabolic disease.